UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                  SCHEDULE 13G
                    Under the Securities Exchange Act of 1934
                                 Amendment No. 1



                           USANA Health Sciences, Inc.
- -------------------------------------------------------------------------------
                                (Name of Issuer)



                         Common Stock, $0.001 par value
- -------------------------------------------------------------------------------
                         (Title of Class of Securities)


                                    90328M107
                  --------------------------------------------
                                 (CUSIP Number)




                                December 31, 2004
- -------------------------------------------------------------------------------
             (Date of Event Which Requires Filing of this Statement)


Check the  appropriate box to designate the rule pursuant to which this Schedule
is filed:

[X] Rule 13d-1(b)

[_] Rule 13d-1(c)

[_] Rule 13d-1(d)



                                Page 1 of 4 pages


- -----------------------
 CUSIP No. 90328M107                   13G
- -----------------------

- ------------------------------------------------------------------------------
 1.   Name of Reporting Person
      I.R.S. Identification No. of above Person

           Goldman Sachs Asset Management, L.P.


- ------------------------------------------------------------------------------
 2.   Check the Appropriate Box if a Member of a Group
                                                                (a) [_]
                                                                (b) [_]

- ------------------------------------------------------------------------------
 3.   SEC Use Only



- ------------------------------------------------------------------------------
 4.   Citizenship or Place of Organization

           Delaware

- ------------------------------------------------------------------------------
                     5.   Sole Voting Power

     Number of                 466,150

      Shares        ----------------------------------------------------------
                     6.   Shared Voting Power
   Beneficially
                               0
     Owned by
                    ----------------------------------------------------------
       Each          7.   Sole Dispositive Power

    Reporting                  872,540

      Person        ----------------------------------------------------------
                     8.   Shared Dispositive Power
       With:
                               0

- ------------------------------------------------------------------------------
 9.   Aggregate Amount Beneficially Owned by Each Reporting Person

           872,540

- ------------------------------------------------------------------------------
10.   Check if the Aggregate Amount in Row (9) Excludes Certain Shares

                                                                    [_]

- ------------------------------------------------------------------------------
11.   Percent of Class Represented by Amount in Row (9)

           4.6%

- ------------------------------------------------------------------------------
12.   Type of Reporting Person

           IA

- ------------------------------------------------------------------------------




                               Page 2 of 4 pages

Item 1(a).         Name of Issuer:
                   USANA Health Sciences, Inc.

Item 4.            Ownership. *

          (a).     Amount beneficially owned:
                   See the response(s) to Item  9 on the attached cover page(s).

          (b).     Percent of Class:
                   See the response(s) to Item 11 on the attached cover page(s).

          (c).     Number of shares as to which such person has:

                   (i).     Sole power to  vote or to direct  the vote:  See the
                            response(s) to Item 5 on the attached cover page(s).

                   (ii).    Shared power to vote or to direct the vote:  See the
                            response(s) to Item 6 on the attached cover page(s).

                   (iii).   Sole power to  dispose or to direct  the disposition
                            of:  See the response(s) to  Item 7  on the attached
                            cover page(s).

                   (iv).    Shared power to dispose or to direct the disposition
                            of:  See the response(s) to  Item 8  on the attached
                            cover page(s).

Item 5.            Ownership of Five Percent or Less of a Class.
                   If this  statement is being filed to report  the fact that as
                   of the date  hereof the  reporting  person  has ceased  to be
                   the beneficial owner of more  than five percent of the class
                   of securities, check the following [X].

Item 10.           Certification.
                   By signing  below I certify that, to the best of my knowledge
                   and belief,  the  securities  referred to above were acquired
                   and are held in the ordinary  course of business and were not
                   acquired  and are not  held  for the  purpose  of or with the
                   effect of changing or  influencing  the control of the issuer
                   of the  securities  and were not acquired and are not held in
                   connection with or as a participant in any transaction having
                   that purpose or effect.


- --------------------------
      *  In accordance with Securities and Exchange  Commission  ("SEC") Release
No.   34-39538   (January  12,  1998),   this  filing  reflects  the  securities
beneficially owned by Goldman Sachs Asset Management, L.P. ("GSAM LP"). GSAM LP,
an investment advisor, disclaims beneficial ownership of any securities managed,
on GSAM LP's behalf, by third parties.





                              Page 3 of 4 pages


                                    SIGNATURE


            After reasonable inquiry and to the best of my knowledge
            and belief,  I certify that the information set forth in
            this statement is true, complete and correct.


Date:  February 10, 2005


                                GOLDMAN SACHS ASSET MANAGEMENT, L.P.


                                By: /s/ Ted Chang
                                   ----------------------------------------
                                Name:   Ted Chang
                                Title:  Attorney-in-fact





                              Page 4 of 4 pages